Syntal Capital Partners’s Albany Molecular Research Inc AMRI Stock Holding History

Syntal Capital Partners’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,153	Closed	-$112K	–	219
2019 Q3	$112K	Buy	+5,153	New	+$112K	0.03%	224

Syntal Capital Partners's AMRI Position: Q4 2019 in Review

Syntal Capital Partners sold out of Albany Molecular Research Inc (AMRI) in Q4 2019, closing a stake of 5,153 shares — an estimated $112K sold.

Syntal Capital Partners first reported a position in AMRI in Q3 2019 and held it in 1 quarter. The position peaked at $112K in Q3 2019. 1 fund tracked by Wall St. Rank holds AMRI as of Q4 2019.

Syntal Capital Partners reported no remaining Albany Molecular Research Inc position as of Q4 2019 after selling out during the quarter.
Syntal Capital Partners sold 5,153 Albany Molecular Research Inc shares in Q4 2019, an estimated $112K.
Syntal Capital Partners first reported a position in Albany Molecular Research Inc in Q3 2019 and held it in 1 quarter.
Syntal Capital Partners's Albany Molecular Research Inc position peaked at $112K in Q3 2019.
1 fund tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2019.

Based on Syntal Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.